Position in ACLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$41,652,562
+$7,505,692 QoQ
Shares Held
362,764
-30.7% QoQ
Ownership
0.620%
of shares outstanding
% of Portfolio
2.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Affinity Asset Advisors, LLC holds $1,518,254,571 across 81 Biotechnology names. ACLX ranks #11 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,284,926 | $108,152,221 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
1,675,000 | $97,401,250 | |
| 3 | ERAS |
Erasca, Inc.
|
5,350,000 | $86,563,000 | |
| 4 | INSM |
INSMED Inc
|
480,000 | $78,489,600 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
2,800,000 | $77,560,000 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $64,519,518 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
1,400,000 | $55,608,000 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
170,000 | $54,772,300 |
All Filings in ACLX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,652,562 | 362,764 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $34,146,870 | 523,725 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,050,000 | 500,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $32,595,750 | 495,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $34,768,000 | 530,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $32,593,250 | 425,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $33,404,000 | 400,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $25,387,400 | 460,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,865,000 | 300,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $18,870,000 | 340,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $14,352,000 | 400,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,154,815 | 226,275 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $6,249,315 | 202,834 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,439,630 | 240,143 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,944,290 | 210,138 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,356,000 | 75,000 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||